NGM BIOPHARMACEUTICALS INC

CUSIP: 62921N105 Class: Common Stock

CHARLES SCHWAB INVESTMENT MANAGEMENT INC's Holding History (CIK: 0000884546)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 284,649 Value ($000) $453 Avg Close Range
Q4 2023
Shares 278,704 Value ($000) $239 Avg Close Range
Q3 2023
Shares 275,064 Value ($000) $294 Avg Close Range
Q2 2023
Shares 271,688 Value ($000) $704 Avg Close Range
Q1 2023
Shares 325,124 Value ($000) $1,327 Avg Close Range
Q4 2022
Shares 327,974 Value ($000) $1,646 Avg Close Range
Q3 2022
Shares 314,559 Value ($000) $4,115 Avg Close Range
Q2 2022
Shares 311,675 Value ($000) $3,996 Avg Close Range
Q1 2022
Shares 299,547 Value ($000) $4,569 Avg Close Range
Q4 2021
Shares 280,468 Value ($000) $4,968 Avg Close Range
Q3 2021
Shares 275,246 Value ($000) $5,786 Avg Close Range
Q2 2021
Shares 182,110 Value ($000) $3,592 Avg Close Range
Q1 2021
Shares 163,973 Value ($000) $4,767 Avg Close Range
Q4 2020
Shares 131,499 Value ($000) $3,984 Avg Close Range
Q3 2020
Shares 129,660 Value ($000) $2,063 Avg Close Range
Q2 2020
Shares 82,061 Value ($000) $1,620 Avg Close Range
Q1 2020
Shares 80,707 Value ($000) $996 Avg Close Range
Q4 2019
Shares 79,052 Value ($000) $1,462 Avg Close Range
Q3 2019
Shares 40,461 Value ($000) $561 Avg Close Range
Q2 2019
Shares 38,487 Value ($000) $564 Avg Close Range